A detailed history of Readystate Asset Management LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 329,917 shares of FOLD stock, worth $2.73 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
329,917
Holding current value
$2.73 Million
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$5.64 - $8.0 $1.86 Million - $2.64 Million
329,917 New
329,917 $1.89 Billion
Q2 2023

Aug 14, 2023

BUY
$10.72 - $13.3 $287,724 - $356,972
26,840 New
26,840 $337 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.32B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.